News Medical on MSN22h
Maternal RSV vaccination timing optimizes newborn immunity through improved antibody transfer
Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...
Medpage Today on MSN16h
NMO Drug Looks Good for IgG4-Related Disease
Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for neuromyelitis ...
Glutamine metabolic switch is key to red blood cell development and disease, researchers reveal
Blood stem cells develop through different stages to become fully mature red blood cells. This fundamental biologic process ...
Breakthrough Genomic Test Can Diagnose Nearly Any Infection
A next-generation metagenomic sequencing test developed at UCSF demonstrates its ability to rapidly and accurately diagnose a ...
eLife3h
TET2 contributes to gluconeogenesis and pathology of type 2 diabetes
Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...
Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease
An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.